CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab
NHS England
Published on NHS Health Family Atamis procurement portal
This tender has closed
The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
NHS England awarded this contract to Amgen Ltd | Sandoz Ltd | Thornton and Ross Ltd | Celltrion Healthcare United Kingdom Limited | Janssen-Cilag Ltd | Accord-UK Ltd worth £230,000,000 on 13 Aug 2024. The contract runs until 31 Aug 2026.
Description
Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024
Offer reference number: CM/TNS/24/5711
CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Awarded suppliers (6)
- Amgen Ltd
- Sandoz Ltd
- Thornton and Ross Ltd
- Celltrion Healthcare United Kingdom Limited
- Janssen-Cilag Ltd
- Accord-UK Ltd
Contact
Identifiers
Explore related tenders
Other tenders from NHS England
View all →External ID: cf-ocds-b5fd17-bd18e8bf-f1dd-455f-8b23-688c3cad9f30 • Added 3 October 2026